Long-term protease inhibitor-containing therapy results in limited improvement in T cell function but not restoration of interleukin-12 production in pediatric patients with AIDS

Journal of Infectious Diseases

Volumn 184, Issue 2, 2001, Pages 201-205

  Chougnet, Claire ^a   Jankelevich, Shirley ^b   Fowke, Keith ^a   Liewehr, David ^a   Steinberg, Seth M ^a   Mueller, Brigitta U ^b   Pizzo, Philip A ^b   Yarchoan, Robert ^b   Shearer, Gene M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; INTERLEUKIN 12; LAMIVUDINE; PROTEINASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; LONG TERM CARE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; T LYMPHOCYTE; VIREMIA; VIRUS INHIBITION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HIV ANTIGENS; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; INTERLEUKIN-12; LAMIVUDINE; MALE; PHYTOHEMAGGLUTININS; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD; ZIDOVUDINE;

EID: 0035879850     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/322006     Document Type: Article

References (15)

1. HIV-induced immunopathogenesis
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
3. Immunological effects of antiretroviral therapy
4. Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir
5. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease
6. A phase I/II study of the protease inhibitor indinavir in children with HIV infection
7. Protease inhibitor and triple-drug therapy: Cellular immune parameters are not restored in pediatric AIDS patients after 6 months of therapy
8. Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine
9. Immunologic and virologic responses to HAART in severely immunocompromised HIV-1 infected children
10. - T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection
11. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response
12. Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children
13. Lymphocyte proliferative responses to HIV antigens as a potential measure of immunological reconstitution in HIV disease
14. Preliminary evaluation of human immunodefeciency virus type-1 (HIV-1) immunogen in children with HIV-1 infection
15. Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production